4-(bromomethyl)benzoic acid,
4-(BROMOMETHYL)BENZOIC ACID,
6232-88-8,
4-Bromomethylbenzoic acid,
alpha-Bromo-p-toluic acid,
Benzoic acid, 4-(bromomethyl)-,
p-(Bromomethyl)benzoic acid,
4-Carboxybenzyl bromide,
4-bromomethyl benzoic acid,
4-Bromomethyl-benzoic acid,
A-BROMO-P-TOLUIC ACID,
p-Carboxybenzyl bromide,
p-bromomethylbenzoic acid,
MFCD00002567,
p-(bromomethyl)-benzoic acid,
.alpha.-Bromo-p-toluic acid,
p-Toluic acid, .alpha.-bromo-,
CQQSQBRPAJSTFB-UHFFFAOYSA-N,
alpha-Bromo-p-toluic acid, 97%,
p-Toluic acid, alpha-bromo-,
EINECS 228-343-3,
NSC 56891,
4-carboxybenzylbromide,
AC1L2KOH,
p-Bromomethyl benzoic acid,
alpha-bromo-4-toluic acid,
ACMC-209n2a,
4-(Bromomethyl)benzoicAcid,
alpha-bromo-4-toluoic acid,
(4-bromomethyl)benzoic acid,
AKOS BB561,
Eprosartan related compound D,
4-(bromomethyl) benzoic acid,
4-(bromomethyl)-benzoic acid,
SCHEMBL220750,
AMBZ0165,
CHEMBL101846,
.alpha.-Bromo-para-toluic acid,
RARECHEM AL BO 0068,
DTXSID7064154,
CTK3J8023,
TIMTEC-BB SBB042644,
ZINC35771,
P-(BROMOETHYL)BENZOIC ACID,
ALPHA-BROMO-P-TOLUYLIC ACID,
AC1Q7380,
ALBB-017953,
CS-B1333,
KS-00000CE6,
NSC56891,
STR04677,
4-(Bromomethyl)benzoic acid, 97%,
AKOS BBS-00006715,
ANW-34160,
BBL008786,
KM0601,
NSC-56891,
SBB042644,
STK318250,
AKOS000103789,
AC-1221,
AM85852,
AS00835,
CM10952,
MCULE-2357888099,
RP26870,
RTR-021429,
TRA0051788,
AJ-08628,
AN-15113,
BC211697,
BP-13470,
SC-22601,
ST005547,
AB1003679,
DB-013437,
TL8004111,
TR-021429,
B0845,
FT-0616712,
ST24043053,
EN300-09230,
A25112,
232B888,
I01-0095,
J-650290,
W-105008,
F0001-2461,
Eprosartan Related Compound D, United States Pharmacopeia (USP) Reference Standard,
alpha-Bromotoluic acid,
a-bromotoluic acid,
C8H7BrO2,
?-Bromo-p-toluic acid,
4-Bromomethylbenzoicacid,
|A-Bromo-p-toluic acid,
(Bromomethyl)benzoic acid,
C8-H7-Br-O2,
CID22599,
alpha-Bromo-p-toluic acid, 97% - 10G 10g,